Searched for
WYETH PHARMACEUTICALS
Wyeth surges 20%; hits upper limit on merger plans with PfizerShares of Wyeth zoomed by 20 per cent to hit the upper circuit limit after the company announced its plan to merge with Pfizer.- Wyeth locked at 20% upper circuit on plan to merge with PfizerWhile, globally Pfizer are Wyeth are single entities, they operate as separate entities in India. The merged entity might benefit on cost f...
- Sun Pharma shares plunge on damages sought by WyethShares of Sun Pharmaceutical dropped nearly 3% as the company said that US-based Wyeth has sought damages worth $960 mn in a patent dispute.
- Wyeth makes $960 mn claims on Protonix patent case: Sun PharmaSun Pharma said US-based Wyeth Pharma has sought damages worth $960 mn related to their ongoing patent dispute over generic version of Prot...
- Pfizer recalls 1 million contraceptive medicine packsPfizer recalled 1 mn birth-control packs after discovering that pills were mixed up inside the packages, possibly putting women at risk.
- Dr Reddy’s Labs launches three generic products in USADr Reddy’s Laboratories announced today that it launched three generic drugs in the US market.
- Wyeth looks strong in the pharma space: Ganesh ShanbhagET Now spoke to Ganesh Shanbhag of SMS Financial Services on his stock picks.
- Pfizer’s growth outlook seen strongThe Pfizer stock has offered better returns to investors than the Bombay Stock Exchange’s (BSE) benchmark index, the Sensex, over the past ...
- Sun Pharma suffers second setback in US patent rowSun Pharmaceutical Industries suffered its second setback in the US litigation within four days after a New Jersey district court decided t...
- Sun gets a boost as FDA rejects rival Osmotica’s pleaSun Pharmaceutical Industries’ plan to launch a copy of US-based Wyeth’s blockbuster anti-depressant capsule Effexor XR got a big boost aft...
- Pharma MNCs want to take a shot at India’s vaccine marketMultinational pharmaceutical companies are now increasingly looking at the Indian vaccine market in a big way. MSD Pharmaceuticals, GlaxoSm...
- Pharma cos may face penalties for overpricingDrugmakers, such as Dr Reddy’s Laboratories, Wyeth, GlaxoSmithKline (GSK) Pharmaceuticals and Alkem Laboratories, may now have to face stat...
- Pfizer agrees to buy Wyeth for $68 bn: ReportsPharmaceutical giant Pfizer is closing in on a $ 68-billion buyout deal with rival Wyeth, according to media reports.
- Sun Pharma launches generic Protonix tabletsSun Pharmaceutical Industries Ltd on Wednesday commercially launched generic Pantoprazole Sodium Delayed Release tablets, 40 mg, which is A...
- Teva’s protonix version sale in US to hit SunIn a development which may impact Sun Pharma’s hopes of a windfall by selling generic versions of Wyeth’s $2.5-billion drug Protonix.
- Wyeth's 'nod' to Sun generic may be tacticalWyeth’s decision to issue a covenant ‘not-to-sue’ (CNS) to Sun Pharmaceutical Industries for seeking approval to sell its version of anti-d...
- Wyeth not to sue Sun Pharma over generic VenlafaxineSun Pharmaceutical Industries has received a covenant ‘not to sue’ from Wyeth over Sun Pharma’s abbreviated new drug application for generi...
- GVK Bio unveils chemistry research centre in HyderabadThe state-of-the-art facility at Nacharam on the city outskirts would house 200 synthetic chemists and scientists working in the area of sy...
- Wyeth Q4 net up 7 fold at Rs 13 crWyeth Ltd on Wednesday posted over 7 fold increase in net profit at Rs 13.25 crore for the quarter ended March 31, as compared to Rs 1.77 c...
- 3 cos sue Wyeth over Zosyn patentThree generic pharmaceutical companies, including one from India, have taken legal action against US pharma major Wyeth.
Load More
